Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
S. Feyerabend
155  Ergebnisse:
Personensuche X
?
1

Clinical benefit and safety profile of darolutamide in pati..:

Feyerabend, S. ; Shore, N. ; Smith, M....
European Urology.  79 (2021)  - p. S1742-S1743 , 2021
Link: https://doi.org/10.1016/..
 
?
2

Baseline neutrophil-to-lymphocyte ratio as a predictive and..:

de Wit, R. ; Wülfing, C. ; Castellano, D....
ESMO Open.  6 (2021)  5 - p. 100241 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Efficacy and safety of rucaparib in previously treated, loc..:

Grivas, P. ; Loriot, Y. ; Morales-Barrera, R....
BMC Cancer.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
4

Pembrolizumab (pembro) for docetaxel-pretreated metastatic ..:

Piulats, J.M. ; Antonarakis, E.S. ; Gross-Goupil, M....
European Urology Open Science.  19 (2020)  - p. e877-e878 , 2020
Link: https://doi.org/10.1016/..
 
?
5

KEYNOTE-365 cohort c updated results: Pembrolizumab (pembro..:

Feyerabend, S. ; Berry, W. ; Fong, P....
European Urology Open Science.  19 (2020)  - p. e875-e876 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Pembrolizumab (pembro) plus olaparib in docetaxel-pretreate..:

Piulats, J.M. ; Yu, E. ; Gravis, G....
European Urology Open Science.  19 (2020)  - p. e873-e874 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Overall survival with abiraterone acetate plus prednisone v..:

Feyerabend, S. ; Saad, F. ; Ito, T....
European Urology Supplements.  18 (2019)  1 - p. e1395-e1396 , 2019
Link: https://doi.org/10.1016/..
 
?
8

ATLAS: A phase 2, open-label study of rucaparib in patients..:

Rodriguez-Vida, A. ; Feyerabend, S. ; Loriot, Y....
European Urology Supplements.  18 (2019)  1 - p. e1838-e1839 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Sparing androgen-deprivation therapy upon treatment with ab..:

Ohlmann, C.H. ; Zilmann, R. ; Rüssel, C....
European Urology Supplements.  18 (2019)  1 - p. e1390-e1391 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Prospective, non-interventional study on the influence of a..:

Suttmann, H. ; Feyerabend, S. ; Gleissner, J....
European Urology Supplements.  15 (2016)  13 - p. e1659-e1660 , 2016
Link: https://doi.org/10.1016/..
 
?
11

762 Results of a phase I/II study in metastatic renal cell ..:

Bedke, J. ; Rausch, S. ; Gouttefangeas, C....
European Urology Supplements.  15 (2016)  3 - p. e762 , 2016
Link: https://doi.org/10.1016/..
 
?
12

549 Results of a prospective phase I/II randomized trial of..:

Bedke, J. ; Gouttefangeas, C. ; Feyerabend, S....
European Urology Supplements.  15 (2016)  3 - p. e549 , 2016
Link: https://doi.org/10.1016/..
 
?
13

SURECAP: Survey and Evaluation of Castration Resistant Pros..:

Merseburger, A.S. ; Kellermann, L. ; Janitzky, A....
European Urology Supplements.  15 (2016)  13 - p. e1658 , 2016
Link: https://doi.org/10.1016/..
 
?
14

2548 The Prostate Cancer Registry: First results from an in..:

Chowdhury, S. ; Birtle, A.J. ; Bjartell, A....
European Journal of Cancer.  51 (2015)  - p. S492 , 2015
Link: https://doi.org/10.1016/..
 
?
15

2560 Baseline serum clusterin level in patients with poor p..:

De Bono, J. ; Higano, C. ; Blumenstein, B....
European Journal of Cancer.  51 (2015)  - p. S497 , 2015
Link: https://doi.org/10.1016/..
 
1-15